首页 | 本学科首页   官方微博 | 高级检索  
     

Raf激酶抑制蛋白与恶性肿瘤
引用本文:王越,杨洁,姚智. Raf激酶抑制蛋白与恶性肿瘤[J]. 国外医学(肿瘤学分册), 2007, 0(1)
作者姓名:王越  杨洁  姚智
作者单位:天津医科大学免疫学教研室,天津医科大学免疫学教研室,天津医科大学免疫学教研室
基金项目:国家973重大基础研究前期研究专项基金(2003CCA04300),国家自然科学基金(30471962)
摘    要:Raf激酶抑制蛋白(RKIP)是磷脂酰乙醇胺结合蛋白家族的成员。RKIP在Raf、核转录因子-κB(NF-κB)及G蛋白偶联受体(GPCR)等蛋白激酶信号传导通路中起重要调节作用。RKIP参与神经发育、心脏功能、精子发生、细胞迁移及巨噬细胞分化,同时还具有丝氨酸蛋白酶活性。近年来众多资料表明,RKIP在多种恶性肿瘤中表达减弱或丢失,其在恶性肿瘤中作用机制已经成为研究的热点,该类研究将为今后肿瘤治疗提供新的靶点。

关 键 词:磷脂酰乙醇胺结合蛋白质  蛋白激酶抑制剂  肿瘤  继发原发性

Raf kinase inhibitor protein and malignant tumor
WANG Yue. Raf kinase inhibitor protein and malignant tumor[J]. Foreign Medical Sciences (Cancer Section), 2007, 0(1)
Authors:WANG Yue
Affiliation:WANG Yue Department of Immunology,Tianjin Medi cal University,Tianjin 300070,China
Abstract:Raf kinase inhibitor protein (RKIP) is a member of the phosphatidylethanolamine-binding protein family.RKIP blocks Raf-induced phosphorylation of mitogen-activated protein kinase kinases (MEK). In addition to its modulation of Raf signaling,RKIP modulates both G-protein signaling and NF-kB activity. RKIP is involved in neural development,cardiac function,spermatogenesis,cell migration and macrophage dif- ferentiation and appears to have serine protease activity.RKIP levels are found to be reduced or lost in many malignant tumors.The more that is defined about RKIP and its role in malignant tumor may help identify RKIP or proteins downstream of RKIP as new targets for cancer treatment.
Keywords:Phosphatidylethanolamine binding protein  Protein kinase inhibitors  Neoplasms  second primary
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号